Evidence map›Paper›PMID 40675953›Full record

ArticleNature communications2025

Type 1 innate lymphoid cell-immature neutrophil axis suppresses acute tissue inflammation.

Kenshiro Matsuda, Natsuki Ide, Yan Xu, Ayana Iijima, Akira Shibuya

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kenshiro MatsudaDepartment of Immunology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.ORCID http://orcid.org/0000-0002-7960-1663
Natsuki IdeDepartment of Immunology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Yan XuDepartment of Immunology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.ORCID http://orcid.org/0000-0003-2790-1629
Ayana IijimaDepartment of Immunology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
Akira ShibuyaDepartment of Immunology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan. ashibuya@md.tsukuba.ac.jp.ORCID http://orcid.org/0000-0002-4480-4858

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 21H04836MEXT | Japan Society for the Promotion of Science (JSPS) 23K14498
6 · The paper itself

Abstract

Immature neutrophils (imNeu) are a minor population of circulating neutrophils that migrate from the bone marrow (BM) into the circulation and inflamed tissues during infection, injury, physical stress, and cancer. However, the underlying mechanism of their mobilization from BM and its pathophysiological significance remains incompletely understood. Here, we show that interferon-gamma (IFN-γ) derived from type 1 innate lymphoid cells (ILC1) enhances the migration of imNeu, but not mature neutrophils, from the BM into inflamed liver tissue with ischemia-reperfusion injury and the blood circulation during polymicrobial sepsis in mice. Mechanistically, the scaffold protein Ahnak, which is specifically expressed in imNeu, underpins Smad7 nuclear translocation in response to IFN-γ, thus downregulating C-X-C chemokine receptor 4 expression critical for neutrophil retention in the BM. Furthermore, imNeu produce interleukin-10 to ameliorate tissue inflammation. Our findings thus reveal the ILC1-imNeu axis that protects tissues from acute inflammation due to injury or microbial infection.

Indexed as

Immunity, InnateInflammationLymphocytesNeutrophilsAnimalsCell MovementInterferon-gammaInterleukin-10LiverMaleMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutReperfusion InjurySepsisInterferon-gammaInterleukin-10Membrane Proteins

Identifiers

PMID40675953
PMCPMC12271315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.